EUVIMED · CrossrefJournal
International Immunopharmacology
ISSN 1567-5769 · Elsevier BV
Latest articles
Targeted co-delivery of SPAG5 siRNA and a PD-L1 inhibitor using nanoliposomes enhances antitumor immunity in a murine prostate cancer model
HSPA12B modulates lung injury and neutrophil-related inflammatory responses in LPS-induced acute lung injury: a potential link to the PKC-PAD4 pathway
Clonal hematopoiesis and cardiovascular immunological memory: From epigenetically reprogrammed hematopoiesis to precision cardiovascular immunology
Reprogramming macrophages toward M1 phenotype to fight against tumors using nanosized armors
Geninthiocin promotes RIG-I-mediated anti-RNA viral signaling responses
Aerobic exercise increases intratumoral CXCR3+CD8+ T-cell accumulation and contributes to tumor control in a murine colorectal cancer model
Aryl hydrocarbon receptor-dependent regulation of polarization in tumor-associated macrophages by galangin and kaempferol in small-cell lung cancer
An Ii-Key-containing HPV16/18 E7 epitope peptide vaccine promotes dendritic cell activation and T-cell immunity in a murine HPV16 tumor model, with greater tumor control upon PD-1 blockade
TREML4 deficiency attenuates renal ischemia-reperfusion injury by limiting oxidative stress and NLRP3 inflammasome-mediated pyroptosis
Targeting immune cells in type 2 diabetes: Immunoregulatory mechanisms of natural products
Engineered Lactococcus lactis delivering soluble PD-1 modulates epithelial PD-L1 signaling and mucosal T-cell immunity in colorectal cancer
Elevated ISG15 reinforces RIG-I/MDA5-linked macrophage–microglia crosstalk during blood–brain barrier disruption in neuromyelitis optica spectrum disorder
SphK1 membrane targeting acts on PKM2 succinylation to fuel synovial hyperplasia in rheumatoid arthritis
USP11 exacerbates intestinal I/R injury by driving NCOA4-mediated ferritinophagy and ferroptosis via Beclin-1 deubiquitination
The P2Y12 antagonist ticagrelor attenuates plasma cell and macrophage inflammatory responses in systemic lupus erythematosus
Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis
Untargeted metabolomics and pathophysiological analyses of 17β-estradiol protection against house dust mite-induced allergic asthma with associated ERα/ERβ and NF-κB p65 expression changes in ovariectomized mice
Mailuoning oral liquid alleviates permanent ischemic stroke by targeting CCR5 to modulate microglial polarization and PI3K/AKT/mTOR axis
Corrigendum to “Effect and mechanism of novel HDAC inhibitor ZDLT-1 in colorectal cancer by regulating apoptosis and inflammation” [Int. Immunopharmacol. 143 (2024) 113333]
Ruscogenin attenuates sepsis-induced multiple organ injury by inhibiting NMMHC IIA
Comparative metabolomic analysis of gingival Crevicular fluid in chronic periodontitis and Peri-Implantitis using LC–MS
Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis
Clinical management strategies for cytokine release syndrome and their impact on CAR T-cell efficacy in lymphoma
m5C demethylase TET2 promotes autophagy and alleviates podocyte injury in diabetic nephropathy by regulating RRAGC
Heparan sulfate sulfation modification in airway mucosal barrier: biosynthetic regulation, pathological implications, and therapeutic targets in allergic respiratory diseases
Altered tryptophan metabolism and AhR-associated epithelial barrier dysfunction in diet-induced obese mice with DSS-induced colitis
Integrated bioinformatics and experimental validation reveal lucanthone as a promising therapeutic agent targeting core genes in psoriasis
Psoriatic lesions show an epidermal transcriptional pattern liking lactate-associated niche-state imbalance with hypoxia-regulatory activity
The ALK inhibitor lorlatinib attenuates lipopolysaccharide-induced neuroinflammation by inhibiting microglial activation and preserving blood–brain barrier integrity
Corrigendum to “Endogenous retroviruses modulate the susceptibility of mice to Staphylococcus aureus-induced mastitis by activating cGAS-STING signaling” [Int. Immunopharmacol. 142(Part B) (2024) 113171]
EUVIMED